Beta-amyloid induced increase in choline flux across PC12 cell membranes

Neuroscience Letters

Volumn 234, Issue 1, 1997, Pages 71-73

  D Allen, David ^a,b   Galdzicki, Zygmunt ^a   Brining, Sheryl K ^a   Fukuyama, Ryuichi ^a   Rapoport, Stanley I ^a   Smith, Quentin R ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Beta amyloid; Choline; Cholinergic vulnerability; PC12 cells; Transport

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CHOLINERGIC NERVE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL MEMBRANE; CHOLINE; PATCH-CLAMP TECHNIQUES; PC12 CELLS; RATS;

EID: 0030842728     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00671-X     Document Type: Article

References (18)

1. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockage by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:1993;567-571.
2. Butterfield D.A., Nicholas M.M., Markesbery W.R. Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease. Neurochem. Res. 10:1985;909-918.
3. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
4. Cullen W.K., Wu J., Anwyl R., Rowan M.J. Beta-amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. NeuroReport. 8:1996;87-92.
5. Ehrenstein, G., Galdzicki, Z. and Lange, G.D., The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease, Biophys. J., 73 (1997) in press.
6. + channels. Science. 264:1994;276-279.
7. Fukuyama R., Wadhwani K.C., Galdzicki Z., Rapoport S.I., Ehrenstein G. β-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer disease. Brain Res. 667:1994;269-272.
8. Galdzicki Z., Fukuyama R., Wadhwani K.C., Rapoport S.I., Ehrenstein G. β-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Res. 646:1994;332-336.
9. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67:1996;277-286.
10. Ikeda Y., Okuyama S., Fujiki Y., Tomoda K., Ohshiro K., Itoh T., Yamauchi T. Changes of acetylcholine and choline concentrations in cerebrospinal fluids of normal subjects and patients with dementia of Alzheimer-type. J. Neural Transm. Suppl. 30:1990;25-32.
11. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
12. Mattson M.P. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging. 16:1995;447-457.
13. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
14. May P.C., Gitter B.D., Waters D.C., Simmons L.K., Becker G.W., Small J.S., Robison P.M. Beta-amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging. 13:1992;605-607.
15. Melega W.P., Howard B.D. Choline and acetylcholine metabolism in PC12 secretory cells. Biochemistry. 20:1981;4477-4483.
16. Slotkin T.A., Seidler F.J., Crain B.J., Bell J.M., Bissette G., Nemeroff C.B. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl. Acad. Sci. USA. 87:1990;2452-2455.
17. Wurtman R.J., Blusztajn J.K., Ulus I.H., Coviella I.L., Growdon J.H., Slack B.E. Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases. Adv. Neurol. 51:1990;117-125.
18. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.